Oct 25, 2025
Donepezil and Brain Health: Complete 2025 Guide
Biosimilars offer major cost savings over brand-name biologics, but insurance barriers like prior authorization and same-tier placement make them hard to access. Patients pay nearly the same out-of-pocket costs - defeating the purpose.